Trial Profile
Phase II trial of tipelukast in patients with mild-to-moderate asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2009
Price :
$35
*
At a glance
- Drugs Tipelukast (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors MediciNova
- 21 Oct 2005 New trial record.